Do I need to take GLP-1 medications forever to keep the benefits?

Based on current evidence, continued use appears necessary to maintain weight loss and blood sugar improvements. However, every patient is different. Talk to your doctor about a personalised long-term plan that may combine medication with diet and lifestyle changes.

What health benefits do GLP-1 medications provide beyond weight loss?

In addition to weight loss, GLP-1 medications were shown to lower HbA1c (a measure of long-term blood sugar), reduce waist circumference, and lower systolic blood pressure. Unfortunately, most of these benefits also reversed after stopping the medication.

How strong is the evidence behind these findings?

This was a systematic review and meta-analysis, which is considered a high level of scientific evidence. However, only 5 qualifying studies with 719 patients were found, so more research is needed to fully confirm these results across larger and more diverse populations.

GLP-1 Drug Benefits Reverse After Stopping Treatment

Key takeaways

✓GLP-1 medications produced significant weight loss (avg. 5.7 kg) and improved blood sugar while being taken
✓Blood pressure and waist circumference also improved meaningfully during treatment
✓Some modest weight loss benefit (about 2.3 kg) remained even months after stopping

Quick specs

Journal	Journal of general internal medicine
Year	2026
PMID	41249646

What This Study Looked At

Researchers reviewed 5 clinical trials involving 719 patients to understand what happens to weight, blood sugar, and other health measures after people stop taking GLP-1 receptor agonist medications (such as semaglutide/Ozempic or liraglutide). They looked at results from at least 6 months after stopping treatment.

What Are GLP-1 Medications?

GLP-1 receptor agonists are a class of injectable or oral medications commonly used to treat type 2 diabetes and obesity. Popular examples include semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda). They work by mimicking a natural gut hormone to reduce appetite, lower blood sugar, and improve heart health markers.

Key Findings While on Treatment

Compared to people not taking these medications, those using GLP-1 drugs experienced significant improvements:

Weight: Lost an average of 5.7 kg (about 12.6 lbs) more than the control group
BMI: Reduced by nearly 3 points more
Waist circumference: Shrank by 3.66 cm more
HbA1c (blood sugar control): Significantly improved
Systolic blood pressure: Dropped by 3.62 mmHg more

What Happens After Stopping?

This is where the findings become especially important for patients. After discontinuing GLP-1 medications, a notable rebound effect was observed:

Weight: Regained an average of 4.13 kg (about 9 lbs)
BMI: Rose by 0.84 points
Waist circumference: Increased by 3.64 cm
HbA1c: Worsened significantly, indicating poorer blood sugar control

The Bottom Line

While some weight loss benefit remained even after stopping (about 2.32 kg less than baseline), the researchers concluded that most of the health benefits are not maintained once treatment stops. To keep the weight off and maintain good blood sugar control, continuous use of these medications appears to be necessary for most people.

What This Means for You

If you are taking or considering a GLP-1 medication, this research suggests you should think of it as a long-term treatment, not a short-term fix. Talk to your healthcare provider before stopping any medication, and discuss a long-term management plan that may include lifestyle changes alongside medication.

References & Sources

Frequently asked questions

Yes, this study found that most people regain a significant amount of weight after stopping GLP-1 medications — an average of about 4 kg (nearly 9 lbs). Blood sugar control also worsens. This suggests these medications work best as a long-term treatment rather than a short course.

Editorial note

This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your diabetes management. Last reviewed: July 16, 2026 by the MDS Diabetes editorial team.

What to do next

📚

GLP-1 Weight Loss Benefits Fade After Stopping Treatment